Ever since the discovery of the caspases almost 20 years ago there have been reports of non-apoptotic roles for apoptotic caspases. Perhaps the clearest paradigm is caspase-8 (casp8), which although essential for triggering the extrinsic apoptotic pathway, is also required for the survival of certain cell populations during development. For example, deletion studies in mice reveal that casp8, its adapter FADD, and its regulator FLIPL may drive either clonal expansion/proliferation or apoptosis of lymphocytes, cardiomyocytes, and some epithelial cell types. This proposal seeks to provide biochemical evidence for the choice between survival and death, while also having the potential to reveal downstream targets of the survival pathway. Thus we provide proof-of-concept tools and knowledge that can lead to the development of compounds to interfere therapeutically in the survival/death axis of proliferative diseases such as cancer. The overarching hypothesis """"""""The survival of cells entering the proliferation program that depends on casp8 activity relies criticaly on the conformation of the casp8 enzyme and cleavage of a limited number of downstream targets"""""""" will be dissected in this study. We propose three interlinked aims to test this hypothesis by defining the biochemical nature of the casp8 enzyme that drives the survival events, defining the targets of this enzyme, and understanding how casp8 promotes survival, and not apoptosis, in specific experimental cellular contexts.
Each aim can be accomplished independently, and the outcome of each aim will substantially further knowledge of the mechanisms of cell survival mediated by casp8. However, the full power of this project is realized when the data from Aim 1 (fundamental mechanisms of casp8 specificity) is coupled to Aim 2 (endogenous pro-survival casp8 targets), and the outcomes of Aims 1 and 2 used to inform the appropriate experimental paradigms for defining the cell's decision between survival and apoptosis (Aim 3). This proposal is significant because it seeks to reveal the molecular mechanism used by casp8 to delineate survival from death, and a successful outcome may impact directly on the selection of protein and small molecule pharmacologic tools that are under clinical development as cancer therapeutics.

Public Health Relevance

A balance of cell survival and cell death is required to maintain the proliferative pathways in normal cells during development and during education of the immune system. This balance is disrupted in tumor cells, leading towards cancer growth. This proposal takes state-of-the-art biochemical approaches to dissect the intersection of cell survival and apoptosis, and thus gain understanding of how to therapeutically intervene to favor one fate over another.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
3R01GM099040-01A1S1
Application #
8616959
Study Section
Cellular Signaling and Regulatory Systems Study Section (CSRS)
Program Officer
Maas, Stefan
Project Start
2012-05-01
Project End
2016-04-30
Budget Start
2012-05-01
Budget End
2013-04-30
Support Year
1
Fiscal Year
2013
Total Cost
$27,234
Indirect Cost
$13,268
Name
Sanford-Burnham Medical Research Institute
Department
Type
DUNS #
020520466
City
La Jolla
State
CA
Country
United States
Zip Code
92037
Lee, Peishan; Zhu, Zilu; Hachmann, Janna et al. (2017) Differing Requirements for MALT1 Function in Peripheral B Cell Survival and Differentiation. J Immunol 198:1066-1080
Salvesen, Guy S; Hempel, Anne; Coll, Nuria S (2016) Protease signaling in animal and plant-regulated cell death. FEBS J 283:2577-98
Brumatti, Gabriela; Ma, Chunyan; Lalaoui, Najoua et al. (2016) The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia. Sci Transl Med 8:339ra69
Hachmann, Janna; Salvesen, Guy S (2016) The Paracaspase MALT1. Biochimie 122:324-38
Poreba, Marcin; Solberg, Rigmor; Rut, Wioletta et al. (2016) Counter Selection Substrate Library Strategy for Developing Specific Protease Substrates and Probes. Cell Chem Biol 23:1023-35
Fasci, Domenico; Anania, Veronica G; Lill, Jennie R et al. (2015) SUMO deconjugation is required for arsenic-triggered ubiquitylation of PML. Sci Signal 8:ra56
Poreba, Marcin; Szalek, Aleksandra; Kasperkiewicz, Paulina et al. (2015) Small Molecule Active Site Directed Tools for Studying Human Caspases. Chem Rev 115:12546-629
Kasperkiewicz, Paulina; Poreba, Marcin; Snipas, Scott J et al. (2015) Design of a Selective Substrate and Activity Based Probe for Human Neutrophil Serine Protease 4. PLoS One 10:e0132818
Hachmann, Janna; Edgington-Mitchell, Laura E; Poreba, Marcin et al. (2015) Probes to monitor activity of the paracaspase MALT1. Chem Biol 22:139-47
Kumar, Sonu; van Raam, Bram J; Salvesen, Guy S et al. (2014) Caspase cleavage sites in the human proteome: CaspDB, a database of predicted substrates. PLoS One 9:e110539

Showing the most recent 10 out of 25 publications